Speaker(s): 

Amitpal Johal MD, Gastroenterology Department Chair, has nothing to disclose.

Harshit Khara, MD, Gastroenterology Director, Geisinger Danville, has nothing to disclose

Moderator(s): 

Leonie Vachon, CRNP, Chief Nurse Practitioner Geisinger Gastroenterology Western Region - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Discuss the Geisinger Health System Policy on prescribing GLP-1 Inhibitors and identify alternative medications for weight loss.
• Review the patient selection, indications,  and applications of Endoscopic Sleeve Gastroplasty (ESG)
• Review the procedural details and clinical outcomes of ESG
• Review the patient pathways for ESG at Geisinger as part of the comprehensive weight management program
• Review the role of ESG as bridge therapy in the management of hepatology, nephrology, transplant, and orthopedic patients

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Karla Leschinsky, PA-C; Leonie Vachon, CRNP; Lorella Thomas, CRNP; Desiree Adams, RN and Alyssa Jones, PharmD have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPPA compliant.